Abbott Laboratories (ABT) News Today $131.90 -1.34 (-1.00%) Closing price 03:59 PM EasternExtended Trading$132.10 +0.19 (+0.15%) As of 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock ABT Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 Time Period Abbott Laboratories (ABT) Benefitted From Better ExecutionMay 12 at 9:47 AM | insidermonkey.comAbbott Laboratories (ABT) Benefitted From Better ExecutionMay 12 at 8:59 AM | finance.yahoo.com2,038 Shares in Abbott Laboratories (NYSE:ABT) Acquired by Ground Swell Capital LLCGround Swell Capital LLC bought a new stake in shares of Abbott Laboratories (NYSE:ABT - Free Report) during the 4th quarter, according to the company in its most recent disclosure with the SEC. The fund bought 2,038 shares of the healthcare product maker's stock, valued at approximately $231,000.May 12 at 6:26 AM | marketbeat.comAbbott Laboratories (NYSE:ABT) Shares Sold by Fred Alger Management LLCFred Alger Management LLC decreased its position in shares of Abbott Laboratories (NYSE:ABT - Free Report) by 29.0% in the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 30,741 shares of the healthcare product maker's stock after selling 12,560May 12 at 5:43 AM | marketbeat.comElefante Mark B Takes $3.71 Million Position in Abbott Laboratories (NYSE:ABT)Elefante Mark B bought a new position in shares of Abbott Laboratories (NYSE:ABT - Free Report) during the fourth quarter, according to its most recent filing with the SEC. The fund bought 32,766 shares of the healthcare product maker's stock, valued at approximately $3,706,000. Abbott LaboratoriesMay 11 at 8:22 AM | marketbeat.comAbbott Laboratories (NYSE:ABT) Shares Sold by Ensign Peak Advisors IncEnsign Peak Advisors Inc cut its holdings in Abbott Laboratories (NYSE:ABT - Free Report) by 6.4% in the 4th quarter, according to its most recent 13F filing with the SEC. The firm owned 3,028,206 shares of the healthcare product maker's stock after selling 208,595 shares during the period. AbbottMay 11 at 7:58 AM | marketbeat.comEthic Inc. Grows Position in Abbott Laboratories (NYSE:ABT)Ethic Inc. increased its holdings in shares of Abbott Laboratories (NYSE:ABT - Free Report) by 12.5% in the fourth quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 188,276 shares of the healthcare product maker's stock after purchasing an aMay 11 at 7:55 AM | marketbeat.comFiduciary Trust Co Purchases 6,772 Shares of Abbott Laboratories (NYSE:ABT)Fiduciary Trust Co lifted its stake in Abbott Laboratories (NYSE:ABT - Free Report) by 2.2% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 308,627 shares of the healthcare product maker's stock after acMay 11 at 7:37 AM | marketbeat.comDeutsche Bank AG Has $1.40 Billion Position in Abbott Laboratories (NYSE:ABT)Deutsche Bank AG lifted its holdings in Abbott Laboratories (NYSE:ABT - Free Report) by 8.0% in the 4th quarter, according to its most recent 13F filing with the SEC. The firm owned 12,418,938 shares of the healthcare product maker's stock after purchasing an additional 921,552 shares during the quMay 10 at 7:26 AM | marketbeat.comEagle Global Advisors LLC Has $1.55 Million Holdings in Abbott Laboratories (NYSE:ABT)Eagle Global Advisors LLC increased its stake in Abbott Laboratories (NYSE:ABT - Free Report) by 268.3% in the 4th quarter, according to the company in its most recent filing with the SEC. The fund owned 13,727 shares of the healthcare product maker's stock after purchasing an additional 10,000 shaMay 10 at 6:50 AM | marketbeat.comAbbott Laboratories (NYSE:ABT) Shares Bought by CoreCap Advisors LLCCoreCap Advisors LLC grew its stake in Abbott Laboratories (NYSE:ABT - Free Report) by 14.5% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 19,012 shares of the healthcare product maker's stock afteMay 10 at 6:29 AM | marketbeat.comCrestline Management LP Has $2.10 Million Stock Position in Abbott Laboratories (NYSE:ABT)Crestline Management LP raised its position in shares of Abbott Laboratories (NYSE:ABT - Free Report) by 37.5% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 18,595 shares of the healthcare productMay 10 at 6:05 AM | marketbeat.comIs Wall Street Bullish or Bearish on Abbott Laboratories Stock?May 9 at 4:21 PM | msn.comCambridge Investment Research Advisors Inc. Trims Stock Position in Abbott Laboratories (NYSE:ABT)Cambridge Investment Research Advisors Inc. trimmed its position in Abbott Laboratories (NYSE:ABT - Free Report) by 0.9% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 312,266 shares of the healthcare productMay 9 at 6:30 AM | marketbeat.comCetera Investment Advisers Reduces Holdings in Abbott Laboratories (NYSE:ABT)Cetera Investment Advisers lowered its stake in shares of Abbott Laboratories (NYSE:ABT - Free Report) by 2.0% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 373,755 shares of the healthcare product maker's stock aftMay 9 at 6:18 AM | marketbeat.comAbbott Laboratories (ABT) Continued Sixth Straight Quarter of Double-Digit GainsMay 8, 2025 | finance.yahoo.comCresset Asset Management LLC Cuts Stock Holdings in Abbott Laboratories (NYSE:ABT)Cresset Asset Management LLC reduced its stake in Abbott Laboratories (NYSE:ABT - Free Report) by 32.7% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 222,862 shares of the healthcare product maker's stock after selling 108,211May 8, 2025 | marketbeat.comCapital Advantage Inc. Buys Shares of 5,087 Abbott Laboratories (NYSE:ABT)Capital Advantage Inc. bought a new position in Abbott Laboratories (NYSE:ABT - Free Report) in the fourth quarter, according to its most recent filing with the SEC. The firm bought 5,087 shares of the healthcare product maker's stock, valued at approximately $575,000. A number of other hedge fundsMay 8, 2025 | marketbeat.comCapitolis Liquid Global Markets LLC Has $20.25 Million Holdings in Abbott Laboratories (NYSE:ABT)Capitolis Liquid Global Markets LLC decreased its position in Abbott Laboratories (NYSE:ABT - Free Report) by 64.2% in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 179,000 shares of the healthcare product maker's stock afterMay 8, 2025 | marketbeat.comBokf Na Has $16.12 Million Stake in Abbott Laboratories (NYSE:ABT)Bokf Na raised its stake in Abbott Laboratories (NYSE:ABT - Free Report) by 3.3% in the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 143,485 shares of the healthcare product maker's stock after purchasing an additiMay 8, 2025 | marketbeat.comCaptrust Financial Advisors Grows Stock Position in Abbott Laboratories (NYSE:ABT)Captrust Financial Advisors raised its holdings in Abbott Laboratories (NYSE:ABT - Free Report) by 2.2% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 385,920 shares of the healthcare product makerMay 8, 2025 | marketbeat.comCary Street Partners Financial LLC Buys New Stake in Abbott Laboratories (NYSE:ABT)Cary Street Partners Financial LLC purchased a new position in shares of Abbott Laboratories (NYSE:ABT - Free Report) in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund purchased 53,795 shares of the healthcare product makMay 8, 2025 | marketbeat.comSchonfeld Strategic Advisors LLC Sells 2,338 Shares of Abbott Laboratories (NYSE:ABT)Schonfeld Strategic Advisors LLC decreased its stake in shares of Abbott Laboratories (NYSE:ABT - Free Report) by 10.8% during the fourth quarter, according to the company in its most recent filing with the SEC. The fund owned 19,373 shares of the healthcare product maker's stock after selling 2,33May 8, 2025 | marketbeat.comJim Cramer Predicts Big Earnings for Abbott Laboratories (ABT): Libre Leads the Way!May 7, 2025 | insidermonkey.comAbbott Laboratories (ABT) Continued Sixth Straight Quarter of Double-Digit GainsMay 7, 2025 | msn.comAbbott Laboratories Q1 Earnings TranscriptMay 7, 2025 | marketbeat.comBrown Advisory Inc. Increases Position in Abbott Laboratories (NYSE:ABT)Brown Advisory Inc. lifted its holdings in Abbott Laboratories (NYSE:ABT - Free Report) by 1.6% during the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 524,871 shares of the healthcare product maker's stock after buying an additional 8,124 shMay 7, 2025 | marketbeat.comBearing Point Capital LLC Makes New $421,000 Investment in Abbott Laboratories (NYSE:ABT)Bearing Point Capital LLC acquired a new stake in Abbott Laboratories (NYSE:ABT - Free Report) in the fourth quarter, according to the company in its most recent disclosure with the SEC. The institutional investor acquired 3,725 shares of the healthcare product maker's stock, valued at approximateMay 7, 2025 | marketbeat.comBaird Financial Group Inc. Sells 19,799 Shares of Abbott Laboratories (NYSE:ABT)Baird Financial Group Inc. lessened its stake in Abbott Laboratories (NYSE:ABT - Free Report) by 1.0% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,924,508 shares of the healthcareMay 6, 2025 | marketbeat.comBanque Transatlantique SA Buys New Position in Abbott Laboratories (NYSE:ABT)Banque Transatlantique SA purchased a new position in shares of Abbott Laboratories (NYSE:ABT - Free Report) in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm purchased 38,104 shares of the healthcare product maker's stock, valued at aMay 6, 2025 | marketbeat.comBanque de Luxembourg S.A. Makes New Investment in Abbott Laboratories (NYSE:ABT)Banque de Luxembourg S.A. purchased a new position in Abbott Laboratories (NYSE:ABT - Free Report) in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor purchased 4,239 shares of the healthcare product maker's stock, vMay 6, 2025 | marketbeat.comBellevue Group AG Reduces Stock Holdings in Abbott Laboratories (NYSE:ABT)Bellevue Group AG trimmed its holdings in shares of Abbott Laboratories (NYSE:ABT - Free Report) by 3.2% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 1,688,660 shares of the healthcare product maker's stock after sellingMay 6, 2025 | marketbeat.comBenjamin Edwards Inc. Has $39.42 Million Stake in Abbott Laboratories (NYSE:ABT)Benjamin Edwards Inc. boosted its position in shares of Abbott Laboratories (NYSE:ABT - Free Report) by 3.5% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 348,332 shares of the healthcare product makerMay 6, 2025 | marketbeat.comBLI Banque de Luxembourg Investments Takes Position in Abbott Laboratories (NYSE:ABT)BLI Banque de Luxembourg Investments bought a new position in shares of Abbott Laboratories (NYSE:ABT - Free Report) during the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund bought 509,521 shares of the healthcare product maker's stoMay 6, 2025 | marketbeat.comAmeriprise Financial Inc. Grows Stake in Abbott Laboratories (NYSE:ABT)Ameriprise Financial Inc. increased its stake in Abbott Laboratories (NYSE:ABT - Free Report) by 6.5% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 12,865,656 shares of the healthcare product maker's stock after purchasingMay 6, 2025 | marketbeat.comAlteri Wealth LLC Takes $283,000 Position in Abbott Laboratories (NYSE:ABT)Alteri Wealth LLC acquired a new position in Abbott Laboratories (NYSE:ABT - Free Report) during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm acquired 2,502 shares of the healthcare product maker's stock, valMay 6, 2025 | marketbeat.comAlyeska Investment Group L.P. Sells 465,770 Shares of Abbott Laboratories (NYSE:ABT)Alyeska Investment Group L.P. reduced its stake in Abbott Laboratories (NYSE:ABT - Free Report) by 44.4% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 582,713 shares of the healMay 5, 2025 | marketbeat.comAbbott Laboratories (NYSE:ABT) Shares Bought by Aptus Capital Advisors LLCAptus Capital Advisors LLC lifted its stake in shares of Abbott Laboratories (NYSE:ABT - Free Report) by 33.4% during the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 172,761 shares of the healthcare product maker's stMay 5, 2025 | marketbeat.comAxa S.A. Trims Stake in Abbott Laboratories (NYSE:ABT)Axa S.A. lessened its stake in shares of Abbott Laboratories (NYSE:ABT - Free Report) by 22.0% in the 4th quarter, according to its most recent disclosure with the SEC. The firm owned 1,109,534 shares of the healthcare product maker's stock after selling 312,735 shares during the period. Axa S.A. oMay 5, 2025 | marketbeat.comAlTi Global Inc. Has $3.29 Million Position in Abbott Laboratories (NYSE:ABT)AlTi Global Inc. lifted its stake in Abbott Laboratories (NYSE:ABT - Free Report) by 12.7% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 28,969 shares of the healthcare product maker's stock after acquiring an additionMay 5, 2025 | marketbeat.comPositive Legal and Market Factors Justify Buy Rating for Abbott LaboratoriesMay 5, 2025 | tipranks.comAbbott Laboratories (NYSE:ABT) Stake Lowered by All Terrain Financial Advisors LLCAll Terrain Financial Advisors LLC trimmed its position in shares of Abbott Laboratories (NYSE:ABT - Free Report) by 52.7% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 2,604 shares of tMay 4, 2025 | marketbeat.com1248 Management LLC Takes $1 Million Position in Abbott Laboratories (NYSE:ABT)1248 Management LLC acquired a new stake in Abbott Laboratories (NYSE:ABT - Free Report) during the fourth quarter, according to its most recent filing with the SEC. The firm acquired 8,837 shares of the healthcare product maker's stock, valued at approximately $1,000,000. Other large investors alsMay 4, 2025 | marketbeat.com5,103 Shares in Abbott Laboratories (NYSE:ABT) Purchased by 4WEALTH Advisors Inc.4WEALTH Advisors Inc. acquired a new stake in Abbott Laboratories (NYSE:ABT - Free Report) during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm acquired 5,103 shares of the healthcare product maker's stock, valued at approximMay 4, 2025 | marketbeat.comWahed Invest LLC Buys 2,700 Shares of Abbott Laboratories (NYSE:ABT)Wahed Invest LLC increased its stake in Abbott Laboratories (NYSE:ABT - Free Report) by 6.5% in the 4th quarter, according to its most recent disclosure with the SEC. The institutional investor owned 44,366 shares of the healthcare product maker's stock after acquiring an additional 2,700 shares dMay 4, 2025 | marketbeat.comMercer Global Advisors Inc. ADV Acquires Shares of 329,702 Abbott Laboratories (NYSE:ABT)Mercer Global Advisors Inc. ADV bought a new position in Abbott Laboratories (NYSE:ABT - Free Report) in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor bought 329,702 shares of the healthcare product maker'sMay 4, 2025 | marketbeat.comCaisse DE Depot ET Placement DU Quebec Reduces Stock Position in Abbott Laboratories (NYSE:ABT)Caisse DE Depot ET Placement DU Quebec decreased its holdings in Abbott Laboratories (NYSE:ABT - Free Report) by 43.3% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 392,848 shares of the healthcare proMay 4, 2025 | marketbeat.comVoleon Capital Management LP Purchases New Shares in Abbott Laboratories (NYSE:ABT)Voleon Capital Management LP bought a new position in Abbott Laboratories (NYSE:ABT - Free Report) in the 4th quarter, according to the company in its most recent filing with the SEC. The institutional investor bought 2,416 shares of the healthcare product maker's stock, valued at approximately $2May 4, 2025 | marketbeat.com2 Stocks, 2 Decades, $200. Is This the Long-Term Dividend Play for Your Portfolio?May 3, 2025 | fool.comAbbott Laboratories (NYSE:ABT) Sets New 12-Month Low - What's Next?Abbott Laboratories (NYSE:ABT) Hits New 52-Week Low - Here's What HappenedMay 3, 2025 | marketbeat.com Get Abbott Laboratories News Delivered to You Automatically Sign up to receive the latest news and ratings for ABT and its competitors with MarketBeat's FREE daily newsletter. Email Address ABT Media Mentions By Week ABT Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ABT News Sentiment▼1.310.85▲Average Medical News Sentiment ABT News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ABT Articles This Week▼3632▲ABT Articles Average Week Get Abbott Laboratories News Delivered to You Automatically Sign up to receive the latest news and ratings for ABT and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies ISRG News BSX News SYK News MDT News BDX News EW News IDXX News RMD News DXCM News STE News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSE:ABT) was last updated on 5/12/2025 by MarketBeat.com Staff From Our PartnersElon just did WHAT!?As you may recall, Biden and the Fed were working on a central bank digital currency, or CBDC. Had they got...Brownstone Research | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredYou’re Being Set Up — Here’s Your ExitLet's not sugarcoat it — your dollars are getting weaker by the hour. Inflation, reckless debt, digital cur...American Alternative | SponsoredA New Economic Shift – How You Can PrepareWhile everyone's focused on the Fed and interest rates... most investors are missing the real story. There'...InvestorPlace | SponsoredSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | SponsoredThe Last Time This Happened, Americans Lost BillionsWall Street leaders just held a secret meeting in Las Vegas. What they discussed mirrors 2006 — and the warnin...Banyan Hill Publishing | SponsoredMost traders are panicking. We’re cashing inMost traders are panicking right now. Bitcoin’s dropping. Altcoins are bleeding. The stock market’s a mess....Crypto Swap Profits | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Abbott Laboratories Please log in to your account or sign up in order to add this asset to your watchlist. Share Abbott Laboratories With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy abt Stock Free abt Stock Alerts